IVD Medical Holding Croissance future

Future contrôle des critères 0/6

Nous ne disposons actuellement pas d'une couverture d'analyste suffisante pour prévoir la croissance et les revenus de IVD Medical Holding.

Informations clés

n/a

Taux de croissance des bénéfices

n/a

Taux de croissance du BPA

Healthcare croissance des bénéfices	21.0%
Taux de croissance des recettes	n/a
Rendement futur des capitaux propres	n/a
Couverture par les analystes	None
Dernière mise à jour	n/a

Mises à jour récentes de la croissance future

Recent updates

IVD Medical Holding Limited's (HKG:1931) Shares Climb 29% But Its Business Is Yet to Catch Up

Oct 14

Additional Considerations Required While Assessing IVD Medical Holding's (HKG:1931) Strong Earnings

Sep 27

IVD Medical Holding Limited's (HKG:1931) 30% Dip In Price Shows Sentiment Is Matching Earnings

Aug 17

Little Excitement Around IVD Medical Holding Limited's (HKG:1931) Earnings As Shares Take 38% Pounding

Jun 07

These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Safely

May 22

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 25

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 03

IVD Medical Holding Limited's (HKG:1931) 28% Price Boost Is Out Of Tune With Earnings

Mar 30

IVD Medical Holding (HKG:1931) Is Paying Out A Larger Dividend Than Last Year

Mar 20

If EPS Growth Is Important To You, IVD Medical Holding (HKG:1931) Presents An Opportunity

Mar 06

IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

Feb 08

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 05

IVD Medical Holding (HKG:1931) Is Increasing Its Dividend To CN¥0.0556

Mar 22

Returns At IVD Medical Holding (HKG:1931) Are On The Way Up

Feb 16

Does IVD Medical Holding (HKG:1931) Have A Healthy Balance Sheet?

Oct 16

Calculating The Intrinsic Value Of IVD Medical Holding Limited (HKG:1931)

Sep 28

IVD Medical Holding (HKG:1931) Has A Rock Solid Balance Sheet

May 16

IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To HK$0.053

Apr 14

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 23

IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

Mar 16

IVD Medical Holding (HKG:1931) Is Experiencing Growth In Returns On Capital

Jul 30

These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Reasonably Well

May 04

There's Been No Shortage Of Growth Recently For IVD Medical Holding's (HKG:1931) Returns On Capital

Apr 20

IVD Medical Holding's (HKG:1931) Stock Price Has Reduced 44% In The Past Year

Mar 05

Are IVD Medical Holding's (HKG:1931) Statutory Earnings A Good Guide To Its Underlying Profitability?

Feb 15

Here's What IVD Medical Holding Limited's (HKG:1931) Shareholder Ownership Structure Looks Like

Jan 31

A Look At The Fair Value Of IVD Medical Holding Limited (HKG:1931)

Jan 16

Does IVD Medical Holding (HKG:1931) Have The Makings Of A Multi-Bagger?

Jan 01

How Does IVD Medical Holding Limited (HKG:1931) Fare As A Dividend Stock?

Dec 17

Have Insiders Been Buying IVD Medical Holding Limited (HKG:1931) Shares This Year?

Dec 02

IVD Medical Holding's(HKG:1931) Share Price Is Down 28% Over The Past Year.

Nov 19

Dans cette section, nous présentons généralement des projections de croissance du chiffre d'affaires et des bénéfices basées sur les estimations consensuelles d'analystes professionnels afin d'aider les investisseurs à comprendre la capacité de l'entreprise à générer des bénéfices. Mais comme IVD Medical Holding n'a pas fourni suffisamment de données passées et n'a pas de prévisions d'analystes, ses bénéfices futurs ne peuvent pas être calculés de manière fiable en extrapolant les données passées ou en utilisant les prévisions des analystes.

Il s'agit d'une situation assez rare car 97% des entreprises couvertes par SimplyWall St disposent de données financières passées.

Prévisions de croissance des bénéfices et des revenus

SEHK:1931 - Estimations futures des analystes et données financières antérieures (CNY Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
6/30/2024	3,065	260	127	165	N/A
3/31/2024	3,076	249	190	229	N/A
12/31/2023	3,088	238	252	292	N/A
9/30/2023	3,019	235	345	387	N/A
6/30/2023	2,950	232	438	481	N/A
3/31/2023	2,849	221	327	366	N/A
12/31/2022	2,749	210	215	250	N/A
9/30/2022	2,735	193	118	146	N/A
6/30/2022	2,720	177	21	42	N/A
3/31/2022	2,726	176	80	103	N/A
12/31/2021	2,731	175	138	163	N/A
9/30/2021	2,682	187	266	293	N/A
6/30/2021	2,634	199	394	423	N/A
3/31/2021	2,531	179	270	297	N/A
12/31/2020	2,428	159	145	170	N/A
9/30/2020	2,415	87	N/A	N/A	N/A
6/30/2020	2,401	15	60	92	N/A
3/31/2020	2,367	145	185	216	N/A
12/31/2019	2,333	275	310	341	N/A
9/30/2019	1,757	321	N/A	N/A	N/A
6/30/2019	1,156	366	8	28	N/A
3/31/2019	785	235	-3	15	N/A
12/31/2018	414	103	-14	2	N/A
9/30/2018	387	114	7	25	N/A
12/31/2017	338	111	N/A	20	N/A
12/31/2016	290	56	N/A	-24	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Données insuffisantes pour déterminer si la croissance des bénéfices prévue de 1931 est supérieure au taux d'épargne ( 2.3% ).

Bénéfices vs marché: Données insuffisantes pour déterminer si les bénéfices de 1931 devraient croître plus rapidement que le marché Hong Kong

Croissance élevée des bénéfices: Données insuffisantes pour déterminer si les bénéfices de 1931 devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Données insuffisantes pour déterminer si les revenus de 1931 devraient croître plus rapidement que le marché Hong Kong.

Croissance élevée des revenus: Données insuffisantes pour déterminer si les revenus de 1931 devraient croître plus rapidement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de 1931 devrait être élevé dans 3 ans

IVD Medical Holding Croissance future

Future contrôle des critères 0/6

Informations clés

Mises à jour récentes de la croissance future

IVD Medical Holding Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2021

Recent updates

Investor sentiment deteriorates as stock falls 18%

IVD Medical Holding Limited's (HKG:1931) Shares Climb 29% But Its Business Is Yet to Catch Up

Additional Considerations Required While Assessing IVD Medical Holding's (HKG:1931) Strong Earnings

Investor sentiment improves as stock rises 43%

First half 2024 earnings released: EPS: CN¥0.093 (vs CN¥0.076 in 1H 2023)

IVD Medical Holding Limited's (HKG:1931) 30% Dip In Price Shows Sentiment Is Matching Earnings

IVD Medical Holding Limited to Report First Half, 2024 Results on Aug 28, 2024

New minor risk - Shareholder dilution

Upcoming dividend of HK$0.062 per share

Investor sentiment deteriorates as stock falls 17%

Little Excitement Around IVD Medical Holding Limited's (HKG:1931) Earnings As Shares Take 38% Pounding

New major risk - Share price stability

These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Safely

Investor sentiment deteriorates as stock falls 16%

Investor sentiment deteriorates as stock falls 17%

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

New minor risk - Share price stability

IVD Medical Holding Limited's (HKG:1931) 28% Price Boost Is Out Of Tune With Earnings

IVD Medical Holding Limited Appoints Law Kim Fai as Chief Financial Officer

Investor sentiment improves as stock rises 15%

IVD Medical Holding (HKG:1931) Is Paying Out A Larger Dividend Than Last Year

Full year 2023 earnings released: EPS: CN¥0.18 (vs CN¥0.16 in FY 2022)

IVD Medical Holding Limited, Annual General Meeting, May 16, 2024

IVD Medical Holding Limited Announces Executive Changes

If EPS Growth Is Important To You, IVD Medical Holding (HKG:1931) Presents An Opportunity

IVD Medical Holding Limited to Report Q4, 2023 Results on Mar 15, 2024

Investor sentiment improves as stock rises 25%

IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

IVD Medical Holding Limited Announces Resignation of Sun Tao as a Non-Executive Director

Calculating The Fair Value Of IVD Medical Holding Limited (HKG:1931)

Investor sentiment improves as stock rises 16%

Now 25% undervalued

IVD Medical Holding's (HKG:1931) Returns On Capital Are Heading Higher

Investor sentiment improves as stock rises 22%

Upcoming dividend of HK$0.03 per share at 7.1% yield

IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To CN¥0.0297

IVD Medical Holding Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on September 13, 2023

First half 2023 earnings released: EPS: CN¥0.076 (vs CN¥0.061 in 1H 2022)

IVD Medical Holding Limited Declares the Payment of an Interim Dividend for the Six Months Ended 30 June 2023, Expected to Be Paid on 6 September 2023

IVD Medical Holding Limited Announces Board Changes

IVD Medical Holding Limited to Report First Half, 2023 Results on Aug 18, 2023

Upcoming dividend of HK$0.056 per share at 5.2% yield

Investor sentiment improves as stock rises 15%

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding (HKG:1931) Is Increasing Its Dividend To CN¥0.0556

Full year 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.13 in FY 2021)

Investor sentiment deteriorates as stock falls 20%

Now 21% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 20%

Returns At IVD Medical Holding (HKG:1931) Are On The Way Up

Less than half of directors are independent

Does IVD Medical Holding (HKG:1931) Have A Healthy Balance Sheet?

Investor sentiment deteriorated over the past week

Calculating The Intrinsic Value Of IVD Medical Holding Limited (HKG:1931)

Upcoming dividend of HK$0.027 per share

IVD Medical Holding Limited Declares Interim Dividend for the Six Months Ended June 30, 2022, Payable on 19 September 2022

First half 2022 earnings released: EPS: CN¥0.061 (vs CN¥0.06 in 1H 2021)

Investor sentiment improved over the past week

Upcoming dividend of HK$0.053 per share

IVD Medical Holding (HKG:1931) Has A Rock Solid Balance Sheet

Less than half of directors are independent

IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To HK$0.053

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding Limited, Annual General Meeting, May 20, 2022

IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

Upcoming dividend of HK$0.027 per share

First half 2021 earnings released: EPS CN¥0.06 (vs CN¥0.029 in 1H 2020)

First half 2021 earnings released: EPS CN¥0.06 (vs CN¥0.029 in 1H 2020)

IVD Medical Holding (HKG:1931) Is Experiencing Growth In Returns On Capital

IVD Medical Holding Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2021

IVD Medical Holding Limited Approves Final Dividend for the Year Ended 31 December 2020

Upcoming dividend of HK$0.036 per share

These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Reasonably Well